U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry EPIMERIC
Molecular Formula C20H25FN8O6S2
Molecular Weight 556.591
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 3
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of CEFLUPRENAM

SMILES

[H][C@]12SCC(\C=C\C[N+](C)(CC)CC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCF)\C3=NSC(N)=N3)C([O-])=O

InChI

InChIKey=XAKKNLNAJBNLPC-MAYKBZFQSA-N
InChI=1S/C20H25FN8O6S2/c1-3-29(2,7-11(22)30)6-4-5-10-8-36-18-13(17(32)28(18)14(10)19(33)34)24-16(31)12(26-35-9-21)15-25-20(23)37-27-15/h4-5,13,18H,3,6-9H2,1-2H3,(H5-,22,23,24,25,27,30,31,33,34)/b5-4+,26-12-/t13-,18-,29?/m1/s1

HIDE SMILES / InChI

Molecular Formula C20H25FN8O6S2
Molecular Weight 556.591
Charge 0
Count
Stereochemistry EPIMERIC
Additional Stereochemistry No
Defined Stereocenters 2 / 3
E/Z Centers 2
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including, http://www.ncbi.nlm.nih.gov/pubmed/1622167, http://www.ncbi.nlm.nih.gov/pubmed/8270493

Cefluprenam is an anti-bacterial agent of broad spectrum. It was active in vitro against different bacteria strains with MIC values from 0.78 ug/ml to 3.13 ug/ml. The drug exerts its bactericidal activity through inhibition of penicillin-binding proteins, showing high affinity to all four subtypes. Cefluprenam was tested for the treatment of respiratory tract infections in phase III study, however the drug development was stopped.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
In vitro evaluation of E1077, a new cephalosporin with a broad antibacterial spectrum.
1992 Mar
In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin with a broad antibacterial spectrum.
1992 Sep
In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin.
1993 Jan
Affinity of E1077, a new cephalosporin, for penicillin-binding proteins of Staphylococcus aureus and its antistaphylococcal activity.
1993 Nov
Therapeutic effects of cefluprenam (CFLP) on polymicrobial infections associated with Enterococcus faecalis in rat pyometra model.
1997 Feb
beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter.
2000 Jan 21
Patents

Patents

Sample Use Guides

In Vivo Use Guide
20 to 40 mg (potency)/kg
Route of Administration: Intravenous
In Vitro Use Guide
Cefluprenam was tested against different bacteria strains. The MIC was determined by visual inspection for lack of turbidity after 24 h of incubation at 37°C. MIC90 for S. aureus and Staphylococcus epidermidis were 0.78 to 1.56 ug/ml. MIC50 for E. faecalis was 1.56 ug/ml. Enterobacteriaceae was inhibited at 0.78 ug/ml. P. vulgaris - at 3.13 ug/ml (MIC90). The MIC90s of the drug for E. cloacae, E. aerogenes, and C. freundii were 0.78, 0.05, and 0.39 ug/ml, respectively. Against S. marcescens the drug was active with MIC90 value of 3.13 ug/ml. MIC50 for P. aeruginosa was 3.13 ug/ml, etc.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:39:11 GMT 2023
Edited
by admin
on Fri Dec 15 16:39:11 GMT 2023
Record UNII
098633Q42P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CEFLUPRENAM
INN   JAN   MART.  
INN  
Official Name English
CEFLUPRENAM [JAN]
Common Name English
CEFLUPRENAM [MART.]
Common Name English
cefluprenam [INN]
Common Name English
(-)-((E)-3-((6R,7R)-7-(2-(5-AMINO-1,2,4-THIADIAZOL-3-YL)GLYOXYLAMIDO)-2-CARBOXY-8-OXO-5-THIA-1-AZABICYCLO (4.2.0)OCT-2-EN-3-YL)ALLYL)(CARBAMOYLMETHYL)ETHYLMETHYLAMMONIUM HYDROXIDE, INNER SALT, 7(SUP 2)-(Z)-(O-(FLUOROMETHYL)OXIME)
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C357
Created by admin on Fri Dec 15 16:39:11 GMT 2023 , Edited by admin on Fri Dec 15 16:39:11 GMT 2023
Code System Code Type Description
PUBCHEM
6536774
Created by admin on Fri Dec 15 16:39:11 GMT 2023 , Edited by admin on Fri Dec 15 16:39:11 GMT 2023
PRIMARY
MESH
C075377
Created by admin on Fri Dec 15 16:39:11 GMT 2023 , Edited by admin on Fri Dec 15 16:39:11 GMT 2023
PRIMARY
FDA UNII
098633Q42P
Created by admin on Fri Dec 15 16:39:11 GMT 2023 , Edited by admin on Fri Dec 15 16:39:11 GMT 2023
PRIMARY
ChEMBL
CHEMBL2074822
Created by admin on Fri Dec 15 16:39:11 GMT 2023 , Edited by admin on Fri Dec 15 16:39:11 GMT 2023
PRIMARY
SMS_ID
100000081801
Created by admin on Fri Dec 15 16:39:11 GMT 2023 , Edited by admin on Fri Dec 15 16:39:11 GMT 2023
PRIMARY
NCI_THESAURUS
C76034
Created by admin on Fri Dec 15 16:39:11 GMT 2023 , Edited by admin on Fri Dec 15 16:39:11 GMT 2023
PRIMARY
INN
7245
Created by admin on Fri Dec 15 16:39:11 GMT 2023 , Edited by admin on Fri Dec 15 16:39:11 GMT 2023
PRIMARY
EPA CompTox
DTXSID001029568
Created by admin on Fri Dec 15 16:39:11 GMT 2023 , Edited by admin on Fri Dec 15 16:39:11 GMT 2023
PRIMARY
EVMPD
SUB07396MIG
Created by admin on Fri Dec 15 16:39:11 GMT 2023 , Edited by admin on Fri Dec 15 16:39:11 GMT 2023
PRIMARY
WIKIPEDIA
CEFLUPRENAM
Created by admin on Fri Dec 15 16:39:11 GMT 2023 , Edited by admin on Fri Dec 15 16:39:11 GMT 2023
PRIMARY
CAS
116853-25-9
Created by admin on Fri Dec 15 16:39:11 GMT 2023 , Edited by admin on Fri Dec 15 16:39:11 GMT 2023
PRIMARY
CHEBI
3488
Created by admin on Fri Dec 15 16:39:11 GMT 2023 , Edited by admin on Fri Dec 15 16:39:11 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY